The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

Researchers have found in a recent study that administration of a higher dose of cefazolin (3 g instead of 2 g) did not ...

followed by maintenance dose (1.5 mg/kg) q 8 h single q.d. Dosing may be substituted by 4.5 mg/kg iv. q.d. Solution: 10 mg/ml (25 vials, 2 ml) US$125 † Metronidazole 500 mg p.o. q 12 h for 14 ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

For cefazolin and cefoxitin, this translates to a minimal initial dose of 2 g, and for metronidazole the initial dose should be 1 g. All intravenous prophylactic antimicrobial agents should be ...

They are administered intravenously (n=31), orally (n=3) or both (n=7). Intravenous administration was either intermittent (n=37) or both intermittent and continuous (n=1), with a loading dose ...

The increased dose was not associated with decreased ... adult patients weighing 120 kg or more who received cefazolin and metronidazole for surgical prophylaxis between July 2012 and June 2021.

Azstarys belongs to a group of drugs called central nervous system stimulants. This article describes the dosages of Azstarys, as well as its strengths and how to take it. To learn more about ...

This article describes the dosages of ivermectin tablets, as well as its strength and how to take it. For a detailed overview of this drug, check out this in-depth ivermectin article. Your dosage ...